Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): A phase I study of the pediatric blood and marrow transplant consortium

✍ Scribed by Sandler, E.S. ;Hagg, R. ;Coppes, M.J. ;Mustafa, M.M. ;Gamis, A. ;Kamani, N. ;Wall, D.

• Publisher: John Wiley and Sons
• Year: 2000
• Tongue: English
• Weight: 157 KB
• Volume: 35
• Category: Article
• ISSN: 0098-1532
• DOI: 10.1002/1096-911x(20001001)35:4<403::aid-mpo2>3.0.co;2-m